Association of a SLC30A8 genetic variant with monotherapy of repaglinide and rosiglitazone effect in newly diagnosed type 2 diabetes patients in China.

Feng Jiang(Nanjing Drum Tower Hospital), Wei Jia(Shanghai Sixth People's Hospital), Rong Zhang(Guizhou University), Jing Lu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Qing Li, Yu Bao(Qingdao University), Wei Yu, Kun San Xiang, Shan Tang(Jilin Agricultural University), Cheng Hu(Shanghai Jiao Tong University)
PubMed
February 1, 2012
Cited by 12


Related Papers